Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-05-30FDA Approved: METOPROLOL TARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for metoprolol tartrate, a generic beta-blocker used to treat cardiovascular…
-
FDA approval · 2007-05-23FDA Approved: AMLODIPINE BESYLATE — Original Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a new original-application generic amlodipine besylate tablet from PD-Rx Pharmaceuticals, Inc. Indications include hypertension…
-
FDA approval · 2007-04-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc., granting approval of a supplemental indicatio…
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., confirming regulatory approval of an upda…
-
FDA approval · 2007-04-12FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., updating the approval status for this generic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-03-01FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under an ANDA. The action approves changes to the g…
-
FDA approval · 2007-01-27FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Atenolol submitted by Zydus Lifesciences Limited.
-
FDA approval · 2007-01-03FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INDERAL LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc. This action au…
-
FDA approval · 2006-12-27FDA Approved: ATENOLOL — Original Application (Ipca Laboratories Limited)
FDA approved the original ANDA for Atenolol by Ipca Laboratories Limited, authorizing a generic atenolol product. Atenolol is used for condi…
-
FDA approval · 2006-12-04FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) submitted by Actavis Pharma, Inc., authorizing changes to th…
-
FDA approval · 2006-09-28FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for nitroglycerin submitted by Prasco Laboratories.
-
FDA approval · 2006-09-13FDA Approved: ATENOLOL — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Atenolol as a generic under ANDA077443 from Rising Pharma Holdings, Inc. for the treatment of hypertension, angina pectoris, an…
-
FDA approval · 2006-07-27FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) from Melinta Therapeutics, LLC. The approval updates the pr…
-
FDA approval · 2006-07-17FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).
-
FDA approval · 2006-05-04FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) sponsored by Melinta Therapeutics, LLC.